BlinatumomabCytokine release syndrome and lack of efficacy: 4 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1935卷 / 1期

关键词：

D O I：

10.1007/s40278-022-28915-5

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：120 / 120

相关论文

共 50 条

[1] BlinatumomabCytokine release syndrome: 2 case reports
Reactions Weekly, 2018, 1695 (1) : 74 - 74
[2] BlinatumomabCytokine release syndrome and neurologic toxicity: 2 case reports
Reactions Weekly, 2020, 1787 (1) : 109 - 109
[3] AntineoplasticsCytokine release syndrome and lack of efficacy: 2 case reports
Reactions Weekly, 2021, 1845 (1) : 52 - 52
[4] BlinatumomabCytokine release syndrome: case report
Reactions Weekly, 2016, 1605 (1) : 33 - 33
[5] BlinatumomabCytokine release syndrome and neurotoxicity following off-label use: 4 case reports
Reactions Weekly, 2020, 1817 (1) : 86 - 86
[6] AntineoplasticsDRESS syndrome and lack of efficacy: 4 case reports
Reactions Weekly, 2022, 1917 (1) : 73 - 73
[7] BlinatumomabCytokine release syndrome: case report
Reactions Weekly, 2025, 2051 (1) : 67 - 67
[8] BlinatumomabCytokine release syndrome: case report
Reactions Weekly, 2025, 2054 (1) : 96 - 96
[9] Multiple drugsCytokine release syndrome and lack of efficacy: 2 case reports
Reactions Weekly, 2024, 2039 (1) : 358 - 358
[10] Multiple drugsCytokine release syndrome and lack of efficacy: 3 case reports
Reactions Weekly, 2024, 2031 (1) : 237 - 237

← 1 2 3 4 5 →